BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20141430)

  • 41. [Real-time reverse-transcriptase polymerase chain reaction in monitoring BCR/ABL transcript levels in chronic myeloid leukemia patients after allogeneic hematopoietic stem cells transplantation].
    Tang BL; Cheng M; Liu HL; Geng LQ; Wu ZT; Sun ZM
    Zhonghua Nei Ke Za Zhi; 2007 Mar; 46(3):224-8. PubMed ID: 17547807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
    Arpinati M; Tolomelli G; Bochicchio MT; Castagnetti F; Amabile M; Bandini G; Bonifazi F; Stanzani M; Rosti G; Martinelli G; Baccarani M
    Biol Blood Marrow Transplant; 2013 May; 19(5):735-40. PubMed ID: 23333776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.
    Bennour A; Ouahchi I; Moez M; Elloumi M; Khelif A; Saad A; Sennana H
    Clin Lab; 2012; 58(5-6):433-9. PubMed ID: 22783572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-time quantification for BCR-ABL transcripts in chronic myeloid leukaemia patients in UKMMC, Malaysia.
    Wong FL; Hamidah NH; Hawa AA; Nurul AN; Leong CF; Saw F; Ainoon O
    Malays J Pathol; 2011 Dec; 33(2):107-12. PubMed ID: 22299211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The differences and correlations of BCR-ABL transcripts between peripheral blood and bone marrow assays are associated with the molecular responses in the bone marrow for chronic myelogenous leukemia.
    Jiang Q; Zhao XY; Qin YZ; Liu YR; Lai YY; Jiang B; Huang XJ
    Am J Hematol; 2012 Dec; 87(12):1065-9. PubMed ID: 22965919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients.
    Koren-Michowitz M; Shimoni A; Daraio F; Crasto F; Lorenzatti R; Volchek Y; Amariglio N; Gottardi E; Saglio G; Nagler A
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1852-5. PubMed ID: 26151304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation.
    Sontakke P; Koczula KM; Jaques J; Wierenga AT; Brouwers-Vos AZ; Pruis M; Günther UL; Vellenga E; Schuringa JJ
    PLoS One; 2016; 11(4):e0153226. PubMed ID: 27055152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolonged treatment with imatinib mesylate in patients with advanced chronic myeloid leukemia causes a reduction of bcr/abl mRNA levels independent of cytogenetic response.
    Cariani E; Capucci M; Micheletti M; Spalenza F; Zanella I; Albertini A; Rossi G
    Ann Hematol; 2003 Jun; 82(6):333-5. PubMed ID: 12734675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Detection of phosphotyrosine in chronic myeloid leukemia cells with PY20 antibody and its clinical applications].
    Tian J; Cheng H; Xu KL; Pan XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1056-60. PubMed ID: 19698259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Philadelphia negative BCR-ABL positive chronic myeloid leukemia mimicking juvenile chronic myeloid leukemia in a 2-year-old child.
    Mahon FX; Labouyrie E; Aurich-Costa J; Dastugue N; Micheau M; Bady C; Perel Y; Bilhou-Nabera C; Reiffers J; Bernard P
    Leuk Lymphoma; 1997 Aug; 26(5-6):615-9. PubMed ID: 9389369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative real-time polymerase chain reaction as an efficient molecular tool for detecting minimal residual disease in Moroccan chronic myeloid leukemia patients.
    Moumen A; Dehbi H; Kottwitz D; El Amrani M; Bouchoutrouch N; El Hadi H; Quessar A; Benchekroun S; Nadifi S; Sefrioui H
    Genet Mol Res; 2015 Feb; 14(1):1044-55. PubMed ID: 25730044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does HOXA9 Gene Expression in Egyptian Chronic Myelogenous Leukemia Patients Affect Disease Progression? A Retrospective Cohort Study.
    Mohamad Ismail MM; Manar MM
    Turk J Haematol; 2013 Dec; 30(4):359-65. PubMed ID: 24385825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Will molecular biology contribute to refine prognosis and to select treatment? The Molecular Biology Committee. Italian Cooperative Study Group on Chronic Myeloid Leukemia.
    Zaccaria A; Martinelli G; Buzzi M; Farabegoli P
    Leuk Lymphoma; 1993; 11 Suppl 1():81-9. PubMed ID: 8251923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atypical chronic myeloid leukemia harboring NUP98-HOXA9.
    Murayama H; Matsushita H; Ando K
    Int J Hematol; 2013 Aug; 98(2):143-4. PubMed ID: 23754767
    [No Abstract]   [Full Text] [Related]  

  • 56. BCR-ABL breakpoint and prognosis in chronic myeloid leukemia.
    Baccarani M; Saglio G; Zaccaria A; Tura S
    Blood; 1992 May; 79(9):2499-500. PubMed ID: 1571566
    [No Abstract]   [Full Text] [Related]  

  • 57. Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression.
    Sloma I; Beer P; Desterke C; Bulaeva E; Bilenky M; Carles A; Moksa M; Raghuram K; Brimacombe C; Lambie K; Turhan AG; Wagner-Ballon O; Gaulard P; Humphries K; Hirst M; Eaves CJ
    Haematologica; 2021 Mar; 106(3):881-885. PubMed ID: 32499242
    [No Abstract]   [Full Text] [Related]  

  • 58. Chronic myeloid leukemia in mother and son: What are the odds?
    Prasad S; Bala S; Chennamaneni R; Lakshmi KM; Sadashivudu G
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27772. PubMed ID: 31033125
    [No Abstract]   [Full Text] [Related]  

  • 59. Aberrant Expression of HOXA5 and HOXA9 in AML.
    Zhao P; Tan L; Ruan J; Wei XP; Zheng Y; Zheng LX; Jiang WQ; Fang WJ
    Asian Pac J Cancer Prev; 2015; 16(9):3941-4. PubMed ID: 25987065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia.
    Spinler K; Hamilton M; Bajaj J; Shima Y; Diaz E; Kritzik M; Reya T
    bioRxiv; 2023 Dec; ():. PubMed ID: 38234720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.